Abstract: . . .  JL. Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haemotol 2003; 122: 160-161. 6. Scarpace SL, Hahn T, Roy H, Brown K, Paplham P, Chanan-Khan A et al. Arterial thrombosis in four patients treated with thalidomide. Leuk Lymphoma 2005; 46: 239-242. 7. Bennet C, Schumock G, Desai A, Kwaan H, Raisch D, Newlin R. Thalidomide-associated deep vein thrombosis and pulmonary embolism. . . .
. . .  Rassam SMV, Ward SM, Turner JT, Laffan M. Thromboembolism in patients on thalidomide for myeloma. Hematology 2002; 7: 51-53. 9. Zangari M, Anaissie E, Barlogie B, Badros A, Desikan R, Gopal AV et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001; 98: 1614-1615.  . . .
. . .  thalidomide therapy (6). 249 Vol: 36 No: 4 Arterial Thrombosis in Refractory Multiple Myeloma August 2006 Page 4 250 SOYSAL, D et al. Arterial Thrombosis in Refractory Multiple Myeloma Turk J Med Sci References 1. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-1080. 2. Zangari M, Barlogie B, Anaissie . . .
. . .  M. Thromboembolism in patients on thalidomide for myeloma. Hematology 2002; 7: 51-53. 9. Zangari M, Anaissie E, Barlogie B, Badros A, Desikan R, Gopal AV et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001; 98: 1614-1615.  . . .
. . .  Thromboembolism in patients on thalidomide for myeloma. Hematology 2002; 7: 51-53. 9. Zangari M, Anaissie E, Barlogie B, Badros A, Desikan R, Gopal AV et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001; 98: 1614-1615.  . . .
. . .  SM, Turner JT, Laffan M. Thromboembolism in patients on thalidomide for myeloma. Hematology 2002; 7: 51-53. 9. Zangari M, Anaissie E, Barlogie B, Badros A, Desikan R, Gopal AV et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001; 98: 1614-1615.  . . .
--3000,6,250,2857,15854